BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36181124)

  • 41. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sugammadex ED90 dose to reverse the rocuronium neuromuscular blockade in obese patients.
    Silva MPD; Matsui C; Kim DD; Vieira JE; Malheiros CA; Mathias LAST
    Rev Col Bras Cir; 2017; 44(1):41-45. PubMed ID: 28489210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and Safety of Sugammadex for the Reversal of Rocuronium-Induced Neuromuscular Blockade in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis.
    Kim YS; Lim BG; Won YJ; Oh SK; Oh JS; Cho SA
    Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833477
    [No Abstract]   [Full Text] [Related]  

  • 44. Potency estimation of sugammadex for the reversal of moderate rocuronium-induced neuromuscular block: a non-randomized dose-response study.
    Kitajima O; Yamamoto M; Takagi S; Suzuki T
    J Anesth; 2020 Jun; 34(3):348-351. PubMed ID: 32095883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane.
    Vanacker BF; Vermeyen KM; Struys MM; Rietbergen H; Vandermeersch E; Saldien V; Kalmar AF; Prins ME
    Anesth Analg; 2007 Mar; 104(3):563-8. PubMed ID: 17312209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of intraoperative muscle relaxation reversal on the success rate of motor evoked potential recording in patients undergoing spinal surgery: a randomized controlled trial.
    Jian M; Liu H; Liang F; Ma B; Wang L; Zhou Y; Qiao H; Han R; Wang C
    BMC Anesthesiol; 2023 Aug; 23(1):290. PubMed ID: 37626303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of neuromuscular blockade and reversal using cisatricurium and neostigmine with rocuronium and sugamadex on the quality of recovery from general anaesthesia for percutaneous closure of left atria appendage.
    Li Q; Yao H; Wu J; Xu M; Xie H; Wu D
    J Cardiothorac Surg; 2022 Aug; 17(1):211. PubMed ID: 36028870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
    Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of intraoperative muscle relaxation reversal on the success rate of motor-evoked potential recording in patients undergoing spinal surgery: study protocol for a randomised controlled trial.
    Jian M; Ma B; Liu H; Wang C; Liang F; Zhou Y; Qiao H; Han R
    BMJ Open; 2022 May; 12(5):e056571. PubMed ID: 35501072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
    Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
    Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effect of rocuronium and sugammadex in hepatic tumor patients without preoperative hepatic impairment].
    Nonaka T; Fujimoto M; Nishi M; Yamamoto T
    Masui; 2013 Mar; 62(3):304-8. PubMed ID: 23544332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Magnesium-induced recurarisation after reversal of rocuronium-induced neuromuscular block with sugammadex.
    Unterbuchner C; Ziegleder R; Graf B; Metterlein T
    Acta Anaesthesiol Scand; 2015 Apr; 59(4):536-40. PubMed ID: 25582520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
    Pühringer FK; Rex C; Sielenkämper AW; Claudius C; Larsen PB; Prins ME; Eikermann M; Khuenl-Brady KS
    Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of sugammadex doses calculated on the basis of corrected body weight and total body weight for the reversal of deep neuromuscular blockade in morbidly obese patients.
    Li D; Wang Y; Zhou Y; Yin C
    J Int Med Res; 2021 Jan; 49(1):300060520985679. PubMed ID: 33499679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex.
    Yoshida F; Suzuki T; Kashiwai A; Furuya T; Konishi J; Ogawa S
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):83-7. PubMed ID: 22103864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rocuronium-induced respiratory paralysis refractory to sugammadex in Charcot-Marie-Tooth disease.
    Hiramatsu S; Moriwaki K; Nakao M; Tsutsumi YM
    Can J Anaesth; 2022 Mar; 69(3):364-368. PubMed ID: 34902106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of sugammadex and pyridostigmine bromide for reversal of rocuronium-induced neuromuscular blockade in short-term pediatric surgery: A prospective randomized study.
    An J; Lee JH; Kim E; Woo K; Kim H; Lee D
    Medicine (Baltimore); 2020 Feb; 99(7):e19130. PubMed ID: 32049831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of sugammadex after neostigmine incomplete reversal of rocuronium-induced neuromuscular blockade.
    de Menezes CC; Peceguini LA; Silva ED; Simões CM
    Rev Bras Anestesiol; 2012 Jul; 62(4):543-7. PubMed ID: 22793970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.